CompletedNot Applicable

Evaluation of HbA1c Levels and Ovarian Reserve and Type 1 Diabetes

Turkey (Türkiye)104 participantsStarted 2018-07-01

Plain-language summary

The human ovary is the target of an autoimmune attack, usually in organ or non-specific autoimmune disorders. Serum anti-Müllerian hormone (AMH) levels decrease early in menopause and menopause is seen in women with type 1 diabetes mellitus (DM1) at a young age. DM1 is aimed to show DM1 relationship with ovarian reserve based on the assumption that it will have lower AMH levels than controls, secondary to bad glycemic control and autoimmune attack in women.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * female patients between 18 and 40 years of age who had consent and had gynecological examination in our polyclinic; * study group for patients with type 1 diabetes mellitus healthy volunteers control group Exclusion Criteria: * Other endocrine and / or autoimmune disorders, polycystic ovary syndrome (PCOS) and * previous surgery, which may reduce ovarian reserves; * medical and / or radiotherapy

What they're measuring

Antral follicle count (AFC)

Timeframe: On the 3rd day of the menstrual cycle

Anti müllerian hormone (AMH)

Timeframe: On the 3rd day of the menstrual cycle

HbA1c

Timeframe: On the 3rd day of the menstrual cycle

Trial details

NCT IDNCT03907618

SponsorKanuni Sultan Suleyman Training and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-01-01

View on ClinicalTrials.gov More Diabetes trials